Ruth R. Wexler

12.5k total citations · 2 hit papers
180 papers, 8.9k citations indexed

About

Ruth R. Wexler is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Ruth R. Wexler has authored 180 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Hematology, 65 papers in Cardiology and Cardiovascular Medicine and 59 papers in Molecular Biology. Recurrent topics in Ruth R. Wexler's work include Blood Coagulation and Thrombosis Mechanisms (66 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (37 papers) and Atrial Fibrillation Management and Outcomes (25 papers). Ruth R. Wexler is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (66 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (37 papers) and Atrial Fibrillation Management and Outcomes (25 papers). Ruth R. Wexler collaborates with scholars based in United States, Germany and Sweden. Ruth R. Wexler's co-authors include Pancras C. Wong, David J. Carini, Andrew T. Chiu, John V. Duncia, A.L. Johnson, Pieter B.M.W.M. Timmermans, William F. Herblin, Robert M. Knabb, P.B.M.W.M. Timmermans and William A. Price and has published in prestigious journals such as Circulation, Blood and Stroke.

In The Last Decade

Ruth R. Wexler

180 papers receiving 8.6k citations

Hit Papers

Angiotensin II receptors and angiotensin II receptor anta... 1989 2026 2001 2013 1993 1989 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Angiotensin II receptors and angiotensin II receptor antagonists.
    1993 1.6k citations Pancras C. Wong, Andrew T. Chiu et al. profile →
  2. Identification of angiotensin II receptor subtypes
    1989 705 citations Andrew T. Chiu, David J. Carini et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruth R. Wexler United States 43 4.5k 3.5k 2.0k 1.7k 1.1k 180 8.9k
Pancras C. Wong United States 46 6.6k 1.5× 4.0k 1.1× 1.2k 0.6× 2.3k 1.4× 1.1k 1.0× 156 10.2k
Pierre Savi France 40 2.9k 0.6× 1.3k 0.4× 452 0.2× 461 0.3× 1.2k 1.1× 90 6.1k
Wolfgang Wienen Germany 28 2.3k 0.5× 1.1k 0.3× 408 0.2× 424 0.3× 440 0.4× 48 4.2k
William J. Greenlee United States 34 693 0.2× 2.2k 0.6× 2.0k 1.0× 227 0.1× 203 0.2× 161 4.5k
Joseph J. Lynch United States 38 2.1k 0.5× 1.8k 0.5× 637 0.3× 118 0.1× 588 0.5× 165 4.3k
David J. Carini United States 35 3.6k 0.8× 2.9k 0.8× 1.1k 0.6× 1.7k 1.0× 78 0.1× 51 6.0k
Stefano Bellosta Italy 34 822 0.2× 2.4k 0.7× 337 0.2× 706 0.4× 152 0.1× 94 7.3k
Luigi Iuliano Italy 47 641 0.1× 1.7k 0.5× 530 0.3× 445 0.3× 257 0.2× 133 5.7k
W. Griffith Humphreys United States 44 716 0.2× 1.6k 0.5× 335 0.2× 456 0.3× 247 0.2× 129 5.7k
Andrew T. Chiu United States 42 5.4k 1.2× 4.3k 1.2× 770 0.4× 2.5k 1.5× 80 0.1× 89 8.0k

Countries citing papers authored by Ruth R. Wexler

Since Specialization
Citations

This map shows the geographic impact of Ruth R. Wexler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth R. Wexler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth R. Wexler more than expected).

Fields of papers citing papers by Ruth R. Wexler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth R. Wexler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth R. Wexler. The network helps show where Ruth R. Wexler may publish in the future.

Co-authorship network of co-authors of Ruth R. Wexler

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth R. Wexler. A scholar is included among the top collaborators of Ruth R. Wexler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth R. Wexler. Ruth R. Wexler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Zilun, Doree Sitkoff, Peter W. Glunz, et al.. (2023). Phthalazinone-based lactams and cyclic ureas as ROCK2 selective inhibitors. Bioorganic & Medicinal Chemistry Letters. 88. 129304–129304. 2 indexed citations
2.
Meng, Wei, Zulan Pi, Karen A. Rossi, et al.. (2021). Identification of a Hydroxypyrimidinone Compound (21) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure. Journal of Medicinal Chemistry. 64(24). 18102–18113. 7 indexed citations
3.
Myers, Michael C., Cullen L. Cavallaro, Shun Su, et al.. (2020). Discovery and SAR of aryl hydroxy pyrimidinones as potent small molecule agonists of the GPCR APJ. Bioorganic & Medicinal Chemistry Letters. 30(7). 126955–126955. 10 indexed citations
4.
Wang, Tammy C., Jennifer X. Qiao, David S. Taylor, et al.. (2018). Discovery and synthesis of tetrahydropyrimidinedione-4-carboxamides as endothelial lipase inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(23-24). 3721–3725. 7 indexed citations
5.
Quan, Mimi L., Donald Pinto, Joanne M. Smallheer, et al.. (2018). Factor XIa Inhibitors as New Anticoagulants. Journal of Medicinal Chemistry. 61(17). 7425–7447. 37 indexed citations
6.
Hu, Zilun, Wei Han, Karen A. Rossi, et al.. (2018). Pyridazine and pyridazinone derivatives as potent and selective factor XIa inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(6). 987–992. 16 indexed citations
7.
Corte, James R., Tianan Fang, Donald Pinto, et al.. (2017). Structure-Based Design of Macrocyclic Factor XIa Inhibitors: Discovery of the Macrocyclic Amide Linker. Journal of Medicinal Chemistry. 60(3). 1060–1075. 29 indexed citations
8.
Wong, Pancras C., Carol A. Watson, Jacques Banville, et al.. (2017). Abstract 13794: An Orally-Active Small-Molecule Antagonist of the Platelet Protease-Activated Receptor-4, BMS-986141, Prevents Aeterial Thrombosis With Low Bleeding Liability in Cynomolgus Monkeys. Circulation. 136. 2 indexed citations
9.
Qiao, Jennifer X., Ying Han, Tammy C. Wang, et al.. (2014). 2-Amino-1,3,4-thiadiazoles in the 7-hydroxy-N-neopentyl spiropiperidine indolinyl series as potent P2Y1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 24(11). 2481–2485. 8 indexed citations
10.
11.
Priestley, E. Scott, Jinglan Zhou, Jiacheng Zhou, et al.. (2013). Discovery and gram-scale synthesis of BMS-593214, a potent, selective FVIIa inhibitor. Bioorganic & Medicinal Chemistry Letters. 23(8). 2432–2435. 23 indexed citations
12.
Yang, Michael G., J. SCOTT WELLS, Brian M. Cochran, et al.. (2007). Design and synthesis of benzoazepinone-derived cyclic malonamides and aminoamides as potent γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(14). 3910–3915. 12 indexed citations
13.
Qiao, Jennifer X., Xuhong Cheng, Joanne M. Smallheer, et al.. (2006). Pyrazole-based factor Xa inhibitors containing N-arylpiperidinyl P4 residues. Bioorganic & Medicinal Chemistry Letters. 17(5). 1432–1437. 18 indexed citations
14.
15.
Xue, Chu‐Biao, John Roderick, James J.‐W. Duan, et al.. (2003). Rational design, synthesis and structure–Activity relationships of a cyclic succinate series of TNF-α converting enzyme inhibitors. Part 1: lead identification. Bioorganic & Medicinal Chemistry Letters. 13(24). 4293–4297. 21 indexed citations
16.
Yao, Wenqing, Michael C. Chao, Zelda R. Wasserman, et al.. (2002). Potent P1′ biphenylmethyl substituted aggrecanase inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(1). 101–104. 27 indexed citations
17.
Sielecki, Thais M., John Wityak, Shaker A. Mousa, et al.. (2000). Ring constrained analogues of β-alanine-containing GPIIb/IIIa receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 10(5). 449–452. 6 indexed citations
18.
Wityak, John, Thais M. Sielecki, Donald Pinto, et al.. (1997). The Discovery of Potent Isoxazoline Glycoprotein IIb/IIIa Receptor Antagonists. Journal of Medicinal Chemistry. 40(8). 1292–1292. 4 indexed citations
19.
Santella, Joseph B., John V. Duncia, Carol L. Ensinger, et al.. (1994). Balanced angiotensin II receptor antagonists. III. The effects of substitution at the imidazole 5-position.. Bioorganic & Medicinal Chemistry Letters. 4(18). 2235–2240. 14 indexed citations
20.
Timmermans, Pieter B.M.W.M., David J. Carini, Andrew T. Chiu, et al.. (1990). Nonpeptide Angiotensin II Receptor Antagonists. American Journal of Hypertension. 3(8_Pt_1). 599–604. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pancras C. Wong Breakdown of academic impact, for papers by Pierre Savi Breakdown of academic impact, for papers by Wolfgang Wienen Breakdown of academic impact, for papers by William J. Greenlee Breakdown of academic impact, for papers by Joseph J. Lynch Breakdown of academic impact, for papers by David J. Carini Breakdown of academic impact, for papers by Stefano Bellosta Breakdown of academic impact, for papers by Luigi Iuliano Breakdown of academic impact, for papers by W. Griffith Humphreys Breakdown of academic impact, for papers by Andrew T. Chiu
Rankless by CCL
2026